Dopl Technologies raises $6.3M in Seed

Dopl Technologies has secured $6.3 million in seed funding, led by SpringTide Ventures, to advance its remotely operated robotic ultrasound system. This investment is intended to bolster the development and regulatory approval process for the platform, which is designed to improve healthcare accessibility in underserved and rural areas. The Bothell, Washington-based company has attracted substantial interest with this funding round, raising its total capital to over $8 million to date.

The core of Dopl’s innovation is a platform that integrates off-the-shelf ultrasound probes with commercially available robots. The system allows remote ultrasound technicians to conduct exams virtually, utilizing haptic feedback for precision. It also features video connectivity facilitating interaction among sonographers, patients, and healthcare personnel on-site. The company is currently in pursuit of FDA clearance, with plans to submit its application next year; obtaining this clearance would enable the shift from in-person to remote robotic examinations, significantly escalating its service reach.

Founded by Dr. James, alongside the company's COO and CMO, Dopl Technologies originated from a collaborative research initiative at the University of Washington focused on innovative care delivery methods. In the context of healthcare's technological landscape, ultrasounds, often compared to stethoscopes due to their diverse diagnostic capabilities, present a viable opportunity for remote care enhancement. Dopl’s system leverages advanced technologies such as fine-motor robotic control and artificial intelligence, aiming to fill a critical gap in healthcare for remote and underserved populations.

The funding arrives at a vital juncture as the remote robotic care industry expands, competing with traditional ultrasound firms and other startups. Noteworthy competitors, including established players from Europe, have already secured FDA clearance for their technologies. Despite the competitive landscape, Dopl distinguishes itself through its advanced haptic feedback technology, promising a more tangible and interactive examination experience for technicians.

Looking ahead, Dopl intends to use the new capital to support staffing increases and navigate the FDA approval process. The company is also eyeing partnerships and opportunities through government initiatives such as the $50 billion Rural Health Transformation Program. Collaborations are already in place with a healthcare collaborative in Washington State. These partnerships are set to further Dopl's mission of enhancing healthcare accessibility, all while positioning the company to capitalize on forthcoming federal funding opportunities.